<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01828151</url>
  </required_header>
  <id_info>
    <org_study_id>gbosco5</org_study_id>
    <nct_id>NCT01828151</nct_id>
  </id_info>
  <brief_title>Noninvasive Positive Airway Pressure Ventilation and Risk of Facial Pressure Ulcers</brief_title>
  <official_title>Noninvasive Positive Airway Pressure Ventilation and Risk of Facial Pressure Ulcers in Patients With Acute Respiratory Failure</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Ospedale S. Giovanni Bosco</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Ospedale S. Giovanni Bosco</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      To assess risk of skin pressure lesions in patients treated with noninvasive mechanical&#xD;
      ventilation.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Noninvasive ventilation improves the outcome of patients with acute respiratory failure;&#xD;
      however patient's discomfort may be responsible for up to a fifth of failures. Scant&#xD;
      literature exists on NIV-related pressure ulcers and their determinants.&#xD;
&#xD;
      Aim of the study is to seek for determinants, if any, associated with the development of&#xD;
      pressure ulcers related to noninvasive ventilation.&#xD;
&#xD;
      Study design: observational. Patients treated with NIV from December 2009 to December 2011&#xD;
      will be analyzed. Main end-points: to seek for variables associated to the development of&#xD;
      NIV-related pressure ulcers in patients with acute respiratory failure.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>December 2009</start_date>
  <completion_date type="Actual">March 2013</completion_date>
  <primary_completion_date type="Actual">December 2011</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Retrospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Risk of skin pressure ulcers in patients treated with noninvasive ventilation for acute respiratory failure.</measure>
    <time_frame>Risk of pressure ulcers within 72 hours from noninvasive ventilation beginning.</time_frame>
    <description>Skin lesions were classified as follows:&#xD;
reddening,&#xD;
loss of skin integrity,&#xD;
necrotic lesion.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Incidence of skin pressure ulcers in patients treated with noninvasive ventilation.</measure>
    <time_frame>Incidence of skin pressure ulcers. Patients will be followed during duration of high dependency unit stay for an average length of stay of 7 days.</time_frame>
    <description>Characterization of skin lesions during noninvasive ventilation in patients with acute respiratory failure.</description>
  </secondary_outcome>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Actual">170</enrollment>
  <condition>Acute Respiratory Failure</condition>
  <arm_group>
    <arm_group_label>Developed skin lesions</arm_group_label>
    <description>Patients treated with noninvasive ventilation for an episode of acute respiratory failure</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Noninvasive ventilation mask</intervention_name>
    <arm_group_label>Developed skin lesions</arm_group_label>
    <other_name>- Oro-nasal mask: Ultra Mirage NV, ResMed Australia</other_name>
    <other_name>- Full-face mask: Performax, Respironics Inc USA</other_name>
    <other_name>- Helmet: Castar R, StarMed - Mirandola Italy</other_name>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        Patients admitted to our high dependency unit for an episode of acute respiratory failure&#xD;
        and treated with noninvasive ventilation.&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  severe dyspnea at rest&#xD;
&#xD;
          -  respiratory rate &gt; 30 per minute&#xD;
&#xD;
          -  PaO2/FiO2 &lt; 200 (despite oxygen with Venturi with a FiO2 og 0.5)&#xD;
&#xD;
          -  use of accessory respiratory muscles&#xD;
&#xD;
          -  pH &lt; 7.35 &gt; 7.10&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  STEMI&#xD;
&#xD;
          -  NSTEMI/Unstable angina&#xD;
&#xD;
          -  Hemodynamic instability&#xD;
&#xD;
          -  Need for immediate endotracheal intubation&#xD;
&#xD;
          -  Inability to protect the airways&#xD;
&#xD;
          -  Impaired sensorium&#xD;
&#xD;
          -  Pulmonary embolism&#xD;
&#xD;
          -  Gastrointestinal bleeding&#xD;
&#xD;
          -  Hematological malignancy or neoplasms with ECOG performance status &gt; 2&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Giovanni Ferrari, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Ospedale S. Giovanni Bosco</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Medicina d'Urgenza - Terapia Subintensiva. Ospedale S. Giovanni Bosco</name>
      <address>
        <city>Torino</city>
        <zip>10154</zip>
        <country>Italy</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Italy</country>
  </location_countries>
  <verification_date>April 2013</verification_date>
  <study_first_submitted>March 21, 2013</study_first_submitted>
  <study_first_submitted_qc>April 5, 2013</study_first_submitted_qc>
  <study_first_posted type="Estimate">April 10, 2013</study_first_posted>
  <last_update_submitted>April 5, 2013</last_update_submitted>
  <last_update_submitted_qc>April 5, 2013</last_update_submitted_qc>
  <last_update_posted type="Estimate">April 10, 2013</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Ospedale S. Giovanni Bosco</investigator_affiliation>
    <investigator_full_name>Giovanni Ferrari</investigator_full_name>
    <investigator_title>Dr</investigator_title>
  </responsible_party>
  <keyword>Pressure ulcer</keyword>
  <keyword>Noninvasive ventilation</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Respiratory Insufficiency</mesh_term>
    <mesh_term>Respiratory Distress Syndrome</mesh_term>
    <mesh_term>Pressure Ulcer</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

